NCT07130578View on ClinicalTrials.gov

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

December 1, 2025

Conditions
Bladder CancerLiquid Biopsy
Interventions
DIAGNOSTIC_TEST

urine tumor DNA/RNA testing

The test analyzes DNA and RNA fragments shed by urothelial carcinoma cells into urine, detecting tumor-specific genetic and epigenetic alterations.

Trial Locations (1)

Unknown

RECRUITING

The second hospital of Tianjin Medical University, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Second Hospital

OTHER